These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35007750)

  • 1. Epidemiologic patterns of hepatitis A infection during the pre-vaccination era: A population-based survey in Tunisia in 2015.
    Saffar F; Sellaoui F; Hechaichi A; Chelly S; Bouguerra H; Cherif A; Talmoudi K; Ben Hadj M; Bahrini A; Letaief H; Bahri O; Chahed MK; Bouafif Ép Ben Alaya N
    Int J Infect Dis; 2022 Apr; 117():162-168. PubMed ID: 35007750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis a virus infection in Central-West Tunisia: an age structured model of transmission and vaccination impact.
    Ayouni K; Naffeti B; Ben Aribi W; Bettaieb J; Hammami W; Ben Salah A; Ammar H; Ben Miled S; Triki H
    BMC Infect Dis; 2020 Aug; 20(1):627. PubMed ID: 32842988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of hepatitis A virus in a cross-sectional study in Mexico: Implications for hepatitis A vaccination.
    Lazcano-Ponce E; Conde-Gonzalez C; Rojas R; DeAntonio R; Romano-Mazzotti L; Cervantes Y; Ortega-Barria E
    Hum Vaccin Immunother; 2013 Feb; 9(2):375-81. PubMed ID: 23291940
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling the hepatitis A epidemiological transition in Brazil and Mexico.
    Van Effelterre T; Guignard A; Marano C; Rojas R; Jacobsen KH
    Hum Vaccin Immunother; 2017 Aug; 13(8):1942-1951. PubMed ID: 28481680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new method for imputing country-level estimates of hepatitis A virus endemicity levels in the Eastern Mediterranean region.
    Itani T; Jacobsen KH; Nguyen T; Wiktor SZ
    Vaccine; 2014 Oct; 32(46):6067-74. PubMed ID: 25236586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-specific seroprevalence of hepatitis a among school children in central Tunisia.
    Letaief A; Kaabia N; Gaha R; Bousaadia A; Lazrag F; Trabelsi H; Ghannem H; Jemni L
    Am J Trop Med Hyg; 2005 Jul; 73(1):40-3. PubMed ID: 16014829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity to Hepatitis-A virus: A nationwide population-based seroprevalence study from Iran.
    Lankarani KB; Honarvar B; Molavi Vardanjani H; Kharmandar A; Gouya MM; Zahraei SM; Baneshi MR; Ali-Akbarpour M; Kazemi M; Seif M; Fard SAZ; Emami A
    Vaccine; 2020 Oct; 38(45):7100-7107. PubMed ID: 32917416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Declining prevalence of hepatitis A virus antibodies among children from low socioeconomic groups reinforces the need for the implementation of hepatitis A vaccination in Brazil.
    Vitral CL; Ospina FL; Artimos S; Melgaço JG; Cruz OG; de Paula VS; Luz SB; Freire M; Gaspar LP; Amado LA; Engstrom EM; Fortes CD; Souza TC; Dias MN; Gaspar AM; Souto FJ
    Mem Inst Oswaldo Cruz; 2012 Aug; 107(5):652-8. PubMed ID: 22850956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of hepatitis A seroprevalence in blood donors in South Tunisia between 2000 and 2007.
    Louati N; Feki L; Rekik H; Feki H; Chaabouni M; Hammami A; Gargouri J; Karray-Hakim H
    Arch Inst Pasteur Tunis; 2009; 86(1-4):69-74. PubMed ID: 20707222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Southern Tunisia: A still high endemicity area for hepatitis A.
    Neffatti H; Lebraud P; Hottelet C; Gharbi J; Challouf T; Roque-Afonso AM
    PLoS One; 2017; 12(4):e0175887. PubMed ID: 28426700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis A and E seroprevalence and associated risk factors: a community-based cross-sectional survey in rural Amazonia.
    Vitral CL; da Silva-Nunes M; Pinto MA; de Oliveira JM; Gaspar AM; Pereira RC; Ferreira MU
    BMC Infect Dis; 2014 Aug; 14():458. PubMed ID: 25149658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of hepatitis A virus infection in Central-West of Tunisia.
    Ayouni K; Kharroubi G; Mallekh R; Hammami W; Marouani R; Mhamdi M; Ben Salah A; Triki H; Bettaieb J
    J Med Virol; 2021 Jun; 93(6):3666-3671. PubMed ID: 32986240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis A Seroprevalence in Mogadishu, Somalia.
    Akbulut UE; Arslan E
    J Trop Pediatr; 2022 Jan; 68(1):. PubMed ID: 35134249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations.
    Ceyhan M; Yildirim I; Kurt N; Uysal G; Dikici B; Ecevit C; Aydogan A; Koc A; Yasa O; Köseoğlu M; Onal K; Hacimustafaoglu M; Celebi S
    J Viral Hepat; 2008 Oct; 15 Suppl 2():69-72. PubMed ID: 18837839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Waning of anti-HAV immunity in Shijiazhuang prefecture, Hebei province, China: a comparison of seroprevalence between 1992 and 2011.
    Chen Y; Zhang XJ; Zhao YL; Zhang YH; Wang SM; Hao ZY; Zhang ZY; Ma JC; Fang Y; Wang XY
    Vaccine; 2014 Oct; 32(47):6227-32. PubMed ID: 25258099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in the seroprevalence of IgG anti-hepatitis A virus between 2001 and 2013: experience at a single center in Korea.
    Chung SJ; Kim TY; Kim SM; Roh M; Yu MY; Lee JH; Oh C; Lee EY; Lee S; Jeon YC; Yoo KS; Sohn JH
    Clin Mol Hepatol; 2014 Jun; 20(2):162-7. PubMed ID: 25032182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis A virus seroprevalence in South Africa - Estimates using routine laboratory data, 2005-2015.
    Haeri Mazanderani A; Motaze NV; McCarthy K; Suchard M; du Plessis NM
    PLoS One; 2019; 14(6):e0216033. PubMed ID: 31242191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Socioeconomic indicators are strong predictors of hepatitis A seroprevalence rates in the Middle East and North Africa.
    Koroglu M; Jacobsen KH; Demiray T; Ozbek A; Erkorkmaz U; Altindis M
    J Infect Public Health; 2017; 10(5):513-517. PubMed ID: 28162965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nationwide Seropositivity of Hepatitis A in Republic of Korea from 2005 to 2014, before and after the Outbreak Peak in 2009.
    Kim KA; Lee A; Ki M; Jeong SH
    PLoS One; 2017; 12(1):e0170432. PubMed ID: 28099530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of hepatitis A virus infection among schoolchildren and adolescents in Kaduna, Nigeria.
    Afegbua SL; Bugaje MA; Ahmad AA
    Trans R Soc Trop Med Hyg; 2013 Oct; 107(10):627-30. PubMed ID: 23959003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.